PATENT CLAIM ANALYSIS

Application Number: 15866924
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "544000"]

Abstract:
The present application relates to compounds and methods for reducing the severity of convulsant activity or epileptic seizures, or for the treatment of chronic or acute pain.

Claim (Index 16):
The method of  claim 1 , wherein the compound represented by the formula (I) is a compound represented by the following formula:

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.20833
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15858183', '15309357', '13216927', '15412667', '12981233']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7662281888965511
- 35 USC 102 Novelty (BERT): 0.5330241863955556
- Combined Prediction Score: 0.7429077886464516
- Mean Citation Score: 318.422452
- Max Citation Score: 323.6101700000001
- Similarity Product: 201.3067750638784

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test